SpOvum Technologies had the privilege of participating in the CME held in Lucknow on 7th September 2025, a prestigious event organized under the aegis of HOPE LOGS and IFS. The gathering brought together more than 150 gynecologists and infertility specialists from across the country, making it an enriching platform for learning, sharing, and networking.
A Highlighted Talk by Dr. Yusuf Alhelou
One of the key highlights of the event was the insightful session by Dr. Yusuf Alhelou, a global key opinion leader and Head of Embryology at a leading IVF clinic chain in the UAE. Dr. Alhelou shared his expertise on “Elevating Embryology through TLM and Lab QA/QC”, drawing from his extensive research and international publications. His talk shed light on the importance of lab quality management and critical diagnostic parameters for improving IVF outcomes.
Engagement at the SpOvum Booth
SpOvum also showcased its services and solutions through a dedicated booth at the event. The booth attracted significant attention from specialists, many of whom expressed interest in our Build and Operate Model for IVF centers and our specialized Lab Services Model. These interactions reaffirmed the relevance of SpOvum’s innovative approach to supporting fertility clinics with technology, expertise, and infrastructure.
A Platform for Knowledge and Collaboration
The CME featured several prominent leaders in the field, including Dr. K.D. Nayar, Dr. Pankaj Talwar, Dr. Sonia Malik, and Dr. Keshav Malhotra, among others. Their presence and contributions made the event a true medical feast of ideas, collaboration, and forward-looking strategies in assisted reproductive technologies.
A Token of Recognition
SpOvum was honored to receive a participation memento from Dr. Geeta Khanna, a gesture that reflects the strong partnership and recognition the company continues to build within the medical fraternity.
At SpOvum, we remain committed to supporting fertility specialists and embryologists by providing cutting-edge solutions, innovative lab models, and collaborative opportunities. Our participation at CME Lucknow 2025 was a step forward in this journey — reinforcing our vision of creating life through technology and expertise.
Stay tuned for more updates and glimpses from the event!
On 25th July 2025, we joined the global celebration of World IVF Day and Embryologist Day, recognizing the silent heroes behind the success of assisted reproductive technologies—our embryologists.
At SpOvum, we take immense pride in our team of embryologists who work across clinics throughout India. Their precision, dedication, and care play a vital role in transforming the dreams of countless families into reality.
To mark this special occasion, a heartfelt gesture was organized across all partner clinics where our embryologists are stationed. The celebration aimed to acknowledge their invaluable contribution and to make them feel truly appreciated.
This day served as a reminder of the critical role embryologists play in the IVF journey, and we extend our sincere gratitude to each one of them for their commitment to excellence in reproductive care.
Your work inspires hope. Your dedication creates life. Happy Embryologist Day!
We’re proud to share that SpOvum Technologies has been featured in ITMatters, in their Tech That Matters series, recognizing our mission to revolutionize fertility care in India through AI-driven, compassionate technology.
The article highlights how SpOvum is addressing critical challenges in IVF — from high costs and fragile procedures to inconsistent outcomes — by developing innovative, locally designed solutions. Our flagship product, RoboICSI®, was noted as a game-changer for its ability to automate the delicate ICSI procedure with greater precision, reduced risk to oocytes, and improved fertilization rates, while also making the process less dependent on elite-level expertise.
ITMatters also spotlighted our commitment to ethics and transparency in AI, our efforts to make advanced fertility technology accessible in Tier II and III cities, and our broader vision to democratize IVF care so that quality treatment becomes a right, not a privilege.
This recognition further fuels our drive to make IVF safer, more efficient, and more affordable for clinics and patients alike — delivering not just cutting-edge tools, but also hope and trust in every step of the journey.
We are proud to share that SpOvum Technologies has been featured in The Economic Times, one of India’s most respected business publications, for our groundbreaking work in applying AI to Assisted Reproductive Technologies (ART).
In an article exploring how AI is transforming India’s healthcare landscape, SpOvum was spotlighted for our pioneering RoboICSI system, which uses artificial intelligence to reduce human error and enhance IVF outcomes. Co-founder Dr. Ramnath Babu was quoted explaining how RoboICSI ensures zero percent oocyte degeneration by recognizing complex patterns across 200+ variables—supporting embryologists and protecting the integrity of every procedure.
With over 2,000 IVF procedures supported and partnerships with 41 IVF clinics across India, SpOvum continues to set new benchmarks in fertility care by combining robotics, AI, and clinical insight.
This recognition is not just a milestone for us—it’s a testament to our vision of making fertility treatments more precise, consistent, and accessible for every aspiring parent.
We’re excited to share that SpOvum Technologies was recently featured in Deccan Herald‘s science section in an article titled “Bioengineered Baby”. The article explores the evolution of IVF and highlights key innovators and technologies shaping the future of assisted reproduction.
Our co-founders, Dr. Santosh Bhargav and Dr. Ramnath Babu, were mentioned for their pioneering work at the intersection of mechanical engineering and reproductive biology. The article spotlighted RoboICSI, our robotic micromanipulation system designed to enhance precision during sperm injection—aiming to reduce egg damage and improve IVF outcomes. It also highlighted our commitment to automation and AI-driven lab data monitoring that supports improved embryo culture environments.
We are thrilled to share that SpOvum Technologies has been featured in YourStory — one of India’s most respected startup and innovation platforms!
The article, titled “This deeptech startup is making fertility treatments smarter, accessible, and effective”, shines a spotlight on our mission to revolutionize the Assisted Reproductive Technology (ART) landscape through AI, robotics, and automation.
The story highlights how our founders, Dr. Ramnath Babu T J and Dr. Santosh Bhargav D B, identified the inefficiencies in traditional IVF labs and took a bold step to transform the system from the ground up. With roots at IISc Bengaluru and backgrounds in mechanical engineering, they’ve built SpOvum to solve core problems in fertility care — from lab precision and compliance to data-driven clinical decisions.
Key Highlights from the Feature:
India faces growing infertility challenges, and IVF remains costly and inconsistent.
SpOvum addresses this through products like RoboICSI, Time-lapse Imaging Incubator, ART Dashboard, and AI Decision Support tools.
Our solutions bring affordability, scalability, and precision to fertility clinics, especially in Tier II and Tier III cities.
Clinics using SpOvum have seen IVF success rates jump from 35% to over 50%.
With 30+ partner clinics across four states and plans to scale to 100 clinics, SpOvum continues to grow rapidly.
We thank YourStory for this recognition and remain committed to building the future of ethical, accessible, and effective fertility care.
In the microscopic world of sperm selection, a subtle motion might be the key to unlocking higher IVF success rates. Scientists have discovered that sperm exhibiting a unique corkscrew-like movement are not only more motile but also significantly more likely to produce high-quality embryos. This insight is reshaping how we approach sperm selection in assisted reproductive technology (ART).
The corkscrew motion isn’t just a quirky dance under the microscope—it’s a powerful biological signal.
What is the Corkscrew Motion?
Under normal conditions, sperm swim in a straightforward, sometimes erratic path. But when challenged with thicker fluids, like the high-viscosity environments used in a new technique called viscosity-gradient micropatterning, only a few sperm show a specialized, spiraling movement—dubbed the corkscrew motion.
This helical movement allows sperm to drill through thicker fluids, mimicking the conditions they would encounter in the female reproductive tract. The sperm that succeed in this microfluidic challenge aren’t just stronger—they’re smarter swimmers with better motility, morphology, and likely genetic health.
Why It Matters in IVF
In conventional ICSI procedures, sperm are chosen manually from a viscous PVP solution. But this new method layers media of different viscosities, forcing sperm to migrate inward through increasing resistance. Those that reach the center are selected for injection.
Interestingly, the sperm that make it through consistently exhibit the corkscrew motion. When these sperm were used in a recent study involving 108 patients, the outcomes improved dramatically:
Fertilization rates jumped to 93.9%
High-quality embryos on Day 3 rose to 89.1%
Day 5 blastocyst formation improved to 51.5%
This is no coincidence. The corkscrew swimmers are clearly doing something right.
Nature’s Filter, Now in the Lab
The corkscrew motion may be nature’s way of filtering out weaker sperm. In the human body, sperm must swim through cervical mucus and uterine fluids—natural high-viscosity environments. Only the fittest reach the egg.
By recreating these conditions in the lab, embryologists can now let physics and biology work together to select the best sperm. It’s a natural filter, redesigned for the Petri dish.
The Future of Fertility Treatment
The beauty of this technique lies in its simplicity. No new tools, no expensive machines—just a clever way of arranging the sperm’s environment to see who rises to the challenge. And with time savings of up to 85% in sperm selection, it’s also streamlining IVF workflows.
As this technique gains traction, we may start seeing the corkscrew motion as a new gold standard in sperm quality—a subtle spin that could bring big changes to fertility success stories worldwide.
In a major breakthrough for fertility science, researchers have developed a physics-based sperm selection technique that significantly improves IVF outcomes while slashing sperm selection time by up to 85%.
The new method, called viscosity-gradient micropatterning, uses layers of fluid with varying thickness to mimic natural sperm navigation. Only the strongest sperm—those that can cut through higher viscosity—make it to the central zone, revealing a unique corkscrew motion linked to higher quality.
Tested on 108 patients in a six-month study, the results were striking:
Fertilization rate: 93.9% (vs. 90.3%)
Day 3 embryo quality: 89.1% (vs. 81.8%)
Blastocyst formation: 51.5% (vs. 44%)
Best of all? The method requires no new equipment—just a smarter way to use what’s already in the lab.
“This could become a game-changer in IVF,” say researchers. Faster, cheaper, and more effective, it promises new hope for couples worldwide.
In the world of assisted reproductive technologies (ART), improving fertilization rates, embryo quality, and overall in vitro fertilization (IVF) outcomes is an ongoing challenge. Recent innovations continue to push the boundaries of what’s possible, and one such breakthrough lies in the optimization of sperm selection during Intracytoplasmic Sperm Injection (ICSI). A recent study investigates the impact of a viscosity-gradient micropatterning technique, an advanced physics-driven microfluidic pathway designed to improve sperm filtration, thus enhancing ART outcomes. But how does it work, and what makes this method so revolutionary?
Understanding the Traditional ICSI Process
ICSI, one of the most common and advanced forms of IVF, involves selecting a single sperm and injecting it directly into an oocyte. Traditionally, sperm are selected using a polyvinylpyrrolidone (PVP) streak in the dish. The sperm selection process, however, is time-consuming and can be challenging, particularly when it comes to determining sperm quality. Moreover, prolonged exposure of sperm and oocytes in the ICSI dish can increase the risk of potential harm to the gametes, including epigenetic changes.
Over the years, researchers have explored various methods to optimize sperm selection, such as Physiological ICSI (PICSI), which uses chemotaxis, and Magnetic Assisted Cell Sorting (MACS), which utilizes magnetic fields to isolate sperm with better DNA integrity. But a new technique, the viscosity-gradient micropatterning approach, aims to address these issues and enhance the ICSI process even further.
The Concept: Viscosity-Gradient Micropatterning
This groundbreaking technique leverages the physics of viscosity gradients to create a selective environment for sperm. The process uses layers of varying PVP concentrations, with each layer exhibiting different viscosities. Sperm are loaded into the outermost layer, and the theory is simple: sperm with the ability to migrate through higher viscosity zones exhibit superior motility and morphology.
The key finding is that sperm that can effectively move from a low-viscosity environment to a higher-viscosity region demonstrate a unique corkscrew motility pattern, which is correlated with better sperm quality. This makes them ideal candidates for injection into oocytes.
In contrast to conventional sperm selection methods, this technique not only allows for a more efficient sperm selection process but also significantly reduces the time spent selecting sperm, improving overall workflow in ART labs.
The Study: Methodology and Results
Study Design and Participants
This study was conducted over six months and involved 108 routine patients. Each patient’s oocytes were divided into two groups: one group underwent traditional sperm selection, while the other used the viscosity-gradient micropatterning technique. The embryos resulting from each group were then observed and compared.
Experimental Setup
The micropatterning process involved creating concentric circles of reducing PVP gradients around a central PVP streak. These circles were connected by bridges, and sperm were loaded into the outermost layer. After incubation, sperm were checked at five-minute intervals to determine which sperm migrated to the central streak—these were selected for ICSI.
Key Findings
The results were impressive:
Fertilization Rate: The fertilization rate for the viscosity-gradient method improved from 90.3% to 93.9%.
Embryo Quality: The percentage of high-quality Day 3 embryos (Grade A+ and Grade B) increased from 81.8% to 89.1%.
Blastocyst Formation: Day 5 blastocyst formation rates rose from 44% to 51.5%.
Furthermore, the sperm selection time was reduced by 80–85%, dramatically optimizing the workflow of embryologists and increasing the efficiency of the entire ART process.
Significance of the Findings
These findings offer exciting implications for the future of ART. The most noteworthy aspect of this study is the corkscrew motility pattern observed in the selected sperm. Sperm exhibiting this unique motion were better able to traverse the higher viscosity zones, an indicator of their superior motility and overall quality. This suggests that using the viscosity-gradient micropatterning technique could help select sperm that have the highest chance of successful fertilization, leading to improved embryo development and IVF success.
Moreover, by reducing sperm selection time, the technique offers significant practical benefits for embryologists, allowing for a faster, more efficient workflow in the laboratory.
Limitations and Considerations
While the results of this study are promising, it’s essential to consider some limitations. The miscible nature of the viscosity gradients necessitates a strict timeline for sperm selection. If the selection process takes too long, the gradients could blend, compromising the method’s effectiveness.
Additionally, the study was conducted in vitro, meaning that further clinical validation is required to confirm whether these results can be reproduced in real-world clinical settings across diverse patient populations.
Wider Implications for ART
The viscosity-gradient micropatterning technique represents a cost-effective, real-time, and easily integrable solution for ICSI. Importantly, it does not require any additional consumables or equipment beyond what is already used in conventional ICSI procedures. This makes it an attractive option for ART centers globally, as it has the potential to improve embryo quality and success rates without incurring significant additional costs.
By optimizing sperm selection and reducing procedural times, this method could make a substantial global impact on fertility treatments, especially in areas where ART resources may be limited or where affordability is a key concern.
Conclusion: A Promising Future for Fertility Treatments
The viscosity-gradient micropatterning technique is a groundbreaking advancement in sperm filtration for ART. By improving sperm selection efficiency, reducing sperm selection time, and enhancing fertilization rates, this method could revolutionize IVF outcomes. Its integration into ART centers worldwide could lead to better success rates and more accessible fertility treatments for patients, offering hope to many individuals and couples seeking to build families.
As further research validates and refines this technique, the future of assisted reproduction looks even brighter, with more precision and better outcomes on the horizon.
We’re excited to share that SpOvum Technologies has been featured in a recent article on IndiaMedToday, a leading healthcare publication, for our groundbreaking collaboration with Khushi Fertility, led by Dr. Rashmi Yogish.
This feature highlights a first-of-its-kind partnership where SpOvum will take the lead in training and upskilling embryologists, ensuring standardised, high-quality practices across all Khushi Fertility centres. Through this strategic alliance, we aim to integrate our advanced Lab Management System (LMS), cutting-edge software, and proprietary hardware into their clinical ecosystem.
In the article, our Co-Founders Dr. Ramnath Babu T J (CEO) and Dr. Santosh Bhargav D B (CTO) shared their vision for building scalable, smart, and patient-centric IVF infrastructure in India. They emphasized how this collaboration will drive real-time R&D, accelerate innovation in AI-powered lab automation, and enhance embryologist performance and patient outcomes.
We’re proud to see our efforts recognised by IndiaMedToday and excited about the future this partnership is shaping for the fertility industry.
